TJC

The Jordan Company, founded in 1982, is a private equity firm specializing in buying and building middle-market companies across various industries through leverage buyouts and recapitalizations. With a focus on long-term investments, they partner with existing owners and management teams to provide liquidity, raise capital for growth, and create equity opportunities. Managed by experienced partners, The Jordan Company has completed over 100 investments and manages approximately $5 billion in committed capital. They typically invest in companies with enterprise values between $100 million and $2 billion and seek to take a majority stake in their portfolio companies. With offices in New York, Chicago, Stamford, and Shanghai, The Jordan Company has a team of investment and operations professionals dedicated to building value over time in their investments.

Ian Arons

Partner

Jonathan Boucher

Partner, Investment Team

Dave Butler

Partner

David M. Butler

Partner

Rich Caputo

Chief Executive Partner

Peter Carbonara

Partner and CFO

Caroline Chiaroni

Associate

Kristin Custar

Partner

Michael R. Denvir

Partner

Ryan Drumm

Vice President

Mark Emery

Partner and Co-Head

Michael Epstein

Senior Controller

Erik Fagan

Partner

Barry Gallup

Partner

Brian Higgins

Partner

Eion Hu

Partner

Dino Lavalle

Associate

Joseph C. Linnen

Partner

Colin Macri

Vice President

Sean Mahon

Vice President

Kristin Mendez

Associate

Jeffrey B. Miller

Partner

Daniel Pezley

Partner

Robert D. Redmond

Vice President, Investment Team

Robbie Redmond

Vice President

Jim Sikorski

Vice President

John Straus

Partner, Investment Team

Peter D. Suffredini

Partner

Ugo Ude

Partner, General Counsel & Chief Compliance Officer

Brad Wilford

Partner

Daniel S. Williams

Partner

Doug Zych

Partner

Past deals in Growth

Young Innovations

Acquisition in 2017
Young Innovations consistently adheres to a three-pronged strategy for growth – acquire, enhance and improve – which provides the foundation for continuing success. They pursue acquisition opportunities to increase their breadth of product and service offerings while increasing the growth of their business. By enhancing their products and expanding customer relationships, they are better able to respond to clinician and patient needs. When they improve their company through cost reductions and rationalizing expenses, they can focus their resources towards acquisitions, enhancements and growth.